Cargando…
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease characterized by arterial and/or venous thrombosis, pregnancy morbidity in the presence of circulating “anti-phospholipid antibodies” (aPL). One of the main target antigens of aPL is β(2)-glycoprotein I (β(2)-GPI). APS may occ...
Autores principales: | Manganelli, Valeria, Truglia, Simona, Capozzi, Antonella, Alessandri, Cristiano, Riitano, Gloria, Spinelli, Francesca Romana, Ceccarelli, Fulvia, Mancuso, Silvia, Garofalo, Tina, Longo, Agostina, Valesini, Guido, Sorice, Maurizio, Conti, Fabrizio, Misasi, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426766/ https://www.ncbi.nlm.nih.gov/pubmed/30923525 http://dx.doi.org/10.3389/fimmu.2019.00460 |
Ejemplares similares
-
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome
por: Manganelli, Valeria, et al.
Publicado: (2017) -
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
por: Truglia, Simona, et al.
Publicado: (2022) -
The Mosaic of “Seronegative” Antiphospholipid Syndrome
por: Conti, Fabrizio, et al.
Publicado: (2014) -
Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts
por: Capozzi, Antonella, et al.
Publicado: (2023) -
Molecular Mechanisms of “Antiphospholipid Antibodies” and Their Paradoxical Role in the Pathogenesis of “Seronegative APS”
por: Misasi, Roberta, et al.
Publicado: (2020)